Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
Stockholders equity, Beginning balance at Dec. 31, 2023	$ 4	$ 250,825	$ (59)	$ 9	$ (195,970)	$ 54,809
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2023	42,422,531
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon at-the-market offering, net of issuance costs	$ 1	29,655				29,656
Issuance of common stock upon at-the-market offering, net of issuance costs (in shares)	8,666,416
Issuance of common stock upon stock option exercises		482				$ 482
Issuance of common stock upon stock option exercises (in shares)	362,947					362,947
Issuance of common stock upon exercise of common warrants		450				$ 450
Issuance of common stock upon exercise of common warrants (in shares)	200,000
Issuance of warrants upon amendment of debt facility		261				261
Vesting of restricted stock units, net of withholding			(26)			(26)
Vesting of restricted stock units, net of withholding (in shares)	27,489
Stock-based compensation		902				902
Unrealized gain (loss) on marketable securities				(9)		(9)
Net Income (Loss)					(10,707)	(10,707)
Stockholders equity, Ending balance at Mar. 31, 2024	$ 5	282,575	(85)		(206,677)	75,818
Stockholders equity, Ending balance (in shares) at Mar. 31, 2024	51,679,383
Stockholders equity, Beginning balance at Dec. 31, 2023	$ 4	250,825	(59)	9	(195,970)	54,809
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2023	42,422,531
Stockholders equity, Ending balance at Dec. 31, 2024	$ 6	300,520	(107)	61	(240,455)	60,025
Stockholders equity, Ending balance (in shares) at Dec. 31, 2024	59,131,149
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units, net of withholding			(17)			(17)
Vesting of restricted stock units, net of withholding (in shares)	92,580
Stock-based compensation		987				987
Unrealized gain (loss) on marketable securities				(50)		(50)
Net Income (Loss)					(14,211)	(14,211)
Stockholders equity, Ending balance at Mar. 31, 2025	$ 6	$ 301,507	$ (124)	$ 11	$ (254,666)	$ 46,734
Stockholders equity, Ending balance (in shares) at Mar. 31, 2025	59,223,729